Journal article
lmmunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma
Katerina Dvorak, Birte Aggeler, John Palting, Penny McKelvie, Andrew Ruszkiewicz, Paul Waring
Pathology | ELSEVIER SCIENCE BV | Published : 2014
Grants
Funding Acknowledgements
Katerina Dvorak and John Patting are currently employed by Ventana Medical Systems Inc. Birte Aggeler is a former employee of Ventana Medical Systems Inc. Paul Waring received research funding from Ventana Medical Systems Inc. to support this study. He is also a former consultant for Roche and former employee of Genentech, a Roche company. Dr Penny McKelvie and Dr Andrew Ruszkiewicz report no conflicts of interest.